2,099 results match your criteria: "Houston Methodist Hospital - DeBakey Heart & Vascular Center[Affiliation]"

Genetic syndromes associated with congenital heart disease.

Heart

September 2024

Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.

Congenital heart defects are the most common type of birth defect, affecting 1% of live births. The underlying cause of congenital heart disease is frequently unknown. However, advances in human genetics and genome technologies have helped expand congenital heart disease pathogenesis knowledge during the last few decades.

View Article and Find Full Text PDF

Is Cardiovascular Regeneration Possible?

Methodist Debakey Cardiovasc J

December 2023

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.

View Article and Find Full Text PDF

Stem Cell Therapy: A Possible Role in the Treatment of Patients with Chronic Limb-Threatening Ischemia?

Methodist Debakey Cardiovasc J

December 2023

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.

Chronic limb-threatening ischemia (CLTI) is a severe form of peripheral arterial disease that portends high morbidity and mortality. Patients may undergo various endovascular or open procedures with the goal of limb salvage. No-option CLTI patients represent a vulnerable population for whom conventional options have been exhausted, or anatomy precludes any attempts at revascularization, often resulting in amputation.

View Article and Find Full Text PDF

Takotsubo cardiomyopathy, also known as stress cardiomyopathy, is a reversible form of cardiomyopathy characterized by reduced ejection fraction with regional wall motion abnormalities, elevated cardiac enzyme levels, and signs of ischemia on electrocardiogram despite the absence of obstructive epicardial coronary artery disease. It is often preceded by intense emotional or physical illness stressors. This case describes a 65-year-old female patient who likely developed takotsubo cardiomyopathy precipitated by the stress of diverticulitis.

View Article and Find Full Text PDF

Rapid advancements in artificial intelligence (AI) have revolutionized numerous sectors, including medical research. Among the various AI tools, OpenAI's ChatGPT, a state-of-the-art language model, has demonstrated immense potential in aiding and enhancing research processes. This review explores the application of ChatGPT in medical hospital level research, focusing on its capabilities for academic writing assistance, data analytics, statistics handling, and code generation.

View Article and Find Full Text PDF

Gene-educational attainment interactions in a multi-population genome-wide meta-analysis identify novel lipid loci.

Front Genet

November 2023

Human Genetics Center, Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.

Article Synopsis
  • Educational attainment is linked to cardiovascular health, and a large genomic study examined how it interacts with cholesterol and triglyceride levels in nearly 226,315 individuals across five population groups.
  • The study identified 18 new genetic variations related to lipid levels—nine for low-density lipoprotein (LDL), seven for high-density lipoprotein (HDL), and two for triglycerides (TG)—some of which interact with educational attainment.
  • Researchers also found five gene targets that potentially interact with FDA-approved drugs, suggesting a connection between genetics and drug responses related to lipid metabolism and overall health.
View Article and Find Full Text PDF

Objective: To assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk.

Design: Systematic review and meta-analysis.

Data Sources: PubMed/Medline, Embase, and Cochrane Library databases up to 31 August 2023.

View Article and Find Full Text PDF

A case series analysis of bicarbonate-based purge solution administration via Impella ventricular assist device.

Am J Health Syst Pharm

February 2024

Advanced Heart Failure and Transplant, Houston Methodist Hospital, Methodist DeBakey Cardiology Associates, Houston, TX, USA.

Purpose: The Impella device historically required a heparin-based purge solution to reduce the risk of biomaterial deposition to maintain pump function. In April 2022, the Food and Drug Administration approved utilization of bicarbonate-based purge solutions (BBPS) as an alternative to heparin for patients who are intolerant to heparin or in whom heparin is contraindicated. The purpose of this case series is to report patient outcomes of Impella support with BBPS use at our institution.

View Article and Find Full Text PDF

Background: The optimal approach to identify individuals with diabetes who are at a high risk for developing heart failure (HF) to inform implementation of preventive therapies is unknown, especially in those without atherosclerotic cardiovascular disease (ASCVD).

Methods: Adults with diabetes and no HF at baseline from 7 community-based cohorts were included. Participants without ASCVD who were at high risk for developing HF were identified using 1-step screening strategies: risk score (WATCH-DM [Weight, Age, Hypertension, Creatinine, HDL-C, Diabetes Control, QRS Duration, MI, and CABG] ≥12), NT-proBNP (N-terminal pro-B-type natriuretic peptide ≥125 pg/mL), hs-cTn (high-sensitivity cardiac troponin T ≥14 ng/L; hs-cTnI ≥31 ng/L), and echocardiography-based diabetic cardiomyopathy (echo-DbCM; left atrial enlargement, left ventricular hypertrophy, or diastolic dysfunction).

View Article and Find Full Text PDF

Infections from prolonged use of axillary intra-aortic balloon pumps (IABPs) have not been well studied. Bloodstream infection (BSI) occurred in 13% of our patients; however, no difference in outcome was noted between those with BSI and those without. Further studies regarding protocol developments that minimize BSI risk are needed.

View Article and Find Full Text PDF

Social disadvantage, coronary artery calcium, and their interplay in the prediction of atherosclerotic cardiovascular disease events.

Atherosclerosis

January 2024

Center for Outcomes Research, Houston Methodist, Houston, TX, USA; Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Background And Aims: Social determinants of health (SDOH) are key for the identification of populations at increased risk of atherosclerotic cardiovascular disease (ASCVD). However, whether at the individual level SDOH improve current ASCVD risk prediction paradigms beyond traditional risk factors and the coronary artery calcium (CAC) score, is unknown. We evaluated the interplay between CAC and SDOH in ASCVD risk prediction.

View Article and Find Full Text PDF
Article Synopsis
  • Workplace violence (WPV) is a serious issue in Pakistan's healthcare sector, affecting the physical and mental well-being of healthcare workers (HCWs) and their job performance.
  • This systematic review analyzed 24 studies involving over 16,000 HCWs to assess the prevalence and types of WPV, identifying verbal abuse as the most common form, especially against female workers, with physical abuse more prevalent among males.
  • The findings highlight a WPV prevalence ranging from 25-100% across different regions, underscoring the urgent need for protective policies and further research to address the issue effectively.
View Article and Find Full Text PDF

Objective: In many studies on aortic disease, women are underrepresented. The present study aims to assess sex-specific morphometric differences and gain more insight into endovascular treatment of the ascending aorta (AA) and arch.

Methods: Electrocardiogram-gated cardiac computed tomography scans of 116 consecutive patients who were evaluated for transcatheter aortic valve replacement were retrospectively reviewed.

View Article and Find Full Text PDF

Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease.

J Am Coll Cardiol

November 2023

National Heart and Lung Institute, Imperial College, London, United Kingdom; Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Background: GadaCAD2 was 1 of 2 international, multicenter, prospective, Phase 3 clinical trials that led to U.S. Food and Drug Administration approval of gadobutrol to assess myocardial perfusion and late gadolinium enhancement (LGE) in adults with known or suspected coronary artery disease (CAD).

View Article and Find Full Text PDF
Article Synopsis
  • JAK inhibitors are effective for treating certain skin conditions but carry a FDA warning due to potential risks, including cardiovascular events and infections, based on data primarily from rheumatoid arthritis patients.
  • The study aimed to assess the risks associated with JAK inhibitors specifically in patients with dermatologic conditions, focusing on mortality and major adverse events.
  • Data from phase 3 clinical trials were analyzed using systematic review methodologies to evaluate the safety of these treatments in dermatology, with results derived from 35 randomized trials.
View Article and Find Full Text PDF

Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide Comparison.

Radiol Cardiothorac Imaging

October 2023

From the Division of Cardiology, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY (C.B.H.); Departments of Medicine and Radiology, Brigham and Women's Hospital, Boston, Mass (S.D.); Blavatnik Family Women's Health Research Institute, Mount Sinai Medical Center, New York, NY (L.J.S.); Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, Va (T.C.V.); The George Washington University School of Medicine, Washington, DC (A.D.C.); Cabrini Health, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia (N.B.); Quanta Diagnostico por Imagem, Curitiba, Brazil (R.J.C., J.V.V.); Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India (G.K.); BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, Scotland (M.C.W.); Houston Methodist DeBakey Heart and Vascular Center, Houston, Tex (M.A.M.); Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, Calif (D.S.B.); Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (A.B.); Division of Cardiology, Centre for Cardiac MRI, Allegheny Health Network, Allegheny General Hospital, Pittsburgh, Pa (R.W.B.); Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (P.E.B.); Lundquist Institute at Harbor-UCLA, Torrance, Calif (M.J.B.); Department of Cardiology, Deborah Heart and Lung Center, Browns Mills, NJ (R.P.B.P.); National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (M.Y.C.); Division of Cardiology, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY (M.P.D., A.S.); Division of Cardiology, Cook County Health, Chicago, Ill (R.D.); Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Ore (M.F.); Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn (J.B.G.); University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, Ala (F.G.H.); Section of Cardiology, Deming Department of Medicine, Tulane University School of Medicine, New Orleans, La (R.C.H.); Duke University Medical Center, Durham, NC (L.K.); Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich (V.L.M.); Division of Cardiology, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY (J.N.); Department of Medicine, Cardiovascular Division, University of Virginia Health System, Charlottesville, Va (P.F.R.L.); Division of Cardiology, Department of Medicine, Brown University Alpert Medical School, Providence, RI (N.R.S.); Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pa (P.S.); St Luke's Mid America Heart Institute, Kansas City, Mo (R.C.T.); Cleveland Clinic Florida, Weston, Fla (D.W.); Technion Israel Institute of Technology, Haifa, Israel (Y.A.C., A.J.E.); Seymour, Paul, and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, 622 W 168th St, PH 10-203, New York, NY 10032 (E.M., A.J.E.); Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY (M.J.R.); Lee Health Heart & Vascular Institute, Fort Myers, Fla (J.L.M.); Department of Cardiology, Loma Linda University Health, Loma Linda, Calif (P.P.); University of Chicago (NorthShore), NorthShore University Health System, Evanston, Ill (M.S.); Department of Science and Technology, Philippine Nuclear Research Institute, Quezon City, Philippines (T.N.B.P.); International Atomic Energy Agency, Vienna, Austria (Y.P., M.D., D.P.); and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY (A.J.E.).

Article Synopsis
  • The study aimed to assess how diagnostic cardiovascular procedure volumes rebounded in the U.S. and abroad during the year after COVID-19 hit, relying on data from 669 facilities worldwide.
  • In the early pandemic (April 2020), procedure volumes dropped significantly but showed a better recovery in U.S. facilities by April 2021 compared to non-U.S. facilities, although high-income non-U.S. countries showed similar recovery rates as the U.S.
  • Regional variations within the U.S. were noted, with the Midwest having the highest recovery rate, but no specific factors were found to predict recovery levels from the initial drop in procedure volumes.
View Article and Find Full Text PDF

Background: High surgical risk may preclude mitral valve replacement in many patients. Transcatheter mitral valve replacement (TMVR) using transfemoral transseptal access is a novel technology for the treatment of mitral regurgitation (MR) in high-risk surgical patients.

Objectives: This analysis evaluates 30-day and 1-year outcomes of the Intrepid TMVR Early Feasibility Study in patients with ≥moderate-severe MR.

View Article and Find Full Text PDF

The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations.

Curr Atheroscler Rep

November 2023

Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, 6550 Fannin St Suite 1801, Houston, TX, 77030, USA.

Purpose Of Review: Stroke is the second leading cause of death and disability-adjusted life years worldwide, and the global lifetime risk of stroke is rising. Moreover, patients with a prior stroke are at high risk of recurrent events. We aimed at reviewing the evidence supporting aggressive secondary prevention strategies for lipid-lowering treatment in this population.

View Article and Find Full Text PDF

The Global Burden of premature cardiovascular disease, 1990-2019.

Int J Cardiol Cardiovasc Risk Prev

December 2023

Division of Cardiovascular Prevention and Wellness, DeBakey Heart and Vascular Center, Houston Methodist, Houston, TX, USA.

Aims: Premature cardiovascular disease (pCVD) definition varies in literature, with age cut-offs ranging from 50-65 years. While there is some literature available on pCVD in North America, comprehensive data on its global burden is still lacking which hinders the development of efficient strategies for early detection and prevention. In this study we aimed to investigate the global trends in pCVD related morbidity and mortality from 1990 to 2019.

View Article and Find Full Text PDF

Introduction: The prospective, nonrandomized, multicenter Q-FFICIENCY study demonstrated the safety and 12-month efficacy of paroxysmal atrial fibrillation (AF) ablation with the novel QDOT MICRO temperature-controlled, contact force-sensing, radiofrequency (RF) catheter. Participants underwent pulmonary vein isolation with very high-power short-duration (vHPSD) mode (90 W, ≤4 s) alone or combined with conventional-power temperature-controlled (CPTC) mode (25-50 W). This study aimed to assess quality-of-life (QOL) and healthcare utilization (HCU) benefits experienced by Q-FFICIENCY study participants.

View Article and Find Full Text PDF